Table 3.
Supportive care needs | Any need | Physical and daily living need | Psychological need | Health system and info need | Sexuality need | Prostate cancer‐specific needa | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Factors | OR (CI 95%) | P | OR (CI 95%) | P | OR (CI 95%) | P | OR (CI 95%) | P | OR (CI 95%) | P | OR (CI 95%) | P |
Age (years) | 0.96 (0.91–1.01) | 0.14 | 0.98 (0.94–1.02) | 0.24 | 0.92 (0.89–0.96) | <0.001 | 0.95 (0.91–0.99) | 0.02 | 0.92 (0.88–0.96) | <0.001 | 0.97 (0.93–1.01) | 0.12 |
Education | ||||||||||||
University/college | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | ||||||
Trade/technical | 0.90 (0.42–1.96) | 0.79 | 1.22 (0.64–2.34) | 0.54 | 0.67 (0.36–1.27) | 0.22 | 1.67 (0.83–3.36) | 0.15 | 0.97 (0.51–1.86) | 0.92 | 0.62 (0.32–1.22) | 0.17 |
High school | 1.38 (0.59–3.22) | 0.46 | 1.30 (0.66–2.59) | 0.45 | 1.20 (0.62–2.31) | 0.59 | 1.52 (0.72–3.21) | 0.27 | 1.08 (0.55–2.13) | 0.83 | 1.41 (0.70–2.84) | 0.34 |
Primary school | 1.28 (0.40–4.17) | 0.69 | 1.06 (0.33–3.40) | 0.92 | 1.98 (0.62–6.29) | 0.25 | 1.28 (0.39–4.17) | 0.69 | 1.27 (0.38–4.27) | 0.70 | 2.27 (0.59–8.69) | 0.23 |
Months since dx | 1.09 (0.92–1.30) | 0.32 | 0.95 (0.83–1.09) | 0.50 | 0.98 (0.86–1.12) | 0.80 | 1.07 (0.93–1.24) | 0.35 | 1.13 (0.98–1.30) | 0.08 | 1.06 (0.92–1.23) | 0.41 |
ADT | ||||||||||||
Absence | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | ||||||
Presence | 0.53 (0.21–1.35) | 0.18 | 2.29 (1.13–4.65) | 0.02 | 1.52 (0.75–3.11) | 0.25 | 2.15 (1.05–4.39) | 0.04 | 0.50 (0.25–1.01) | 0.06 | 0.39 (0.18–0.86) | 0.02 |
BSI‐18 | ||||||||||||
Somatisation | 1.28 (0.96–1.71) | 0.10 | 1.24 (1.05–1.48) | 0.01 | 1.29 (1.08–1.54) | 0.005 | 1.09 (0.93–1.28) | 0.27 | 0.89 (0.76–1.04) | 0.14 | 1.08 (0.89–1.30) | 0.46 |
Depression | 0.93 (0.72–1.20) | 0.56 | 1.02 (0.88–1.19) | 0.80 | 1.09 (0.93–1.28) | 0.30 | 0.96 (0.83–1.11) | 0.59 | 1.00 (0.84–1.18) | 0.97 | 1.01 (0.84–1.21) | 0.93 |
Anxiety | 1.44 (1.00–2.08) | 0.05 | 1.17 (0.97–1.40) | 0.10 | 1.08 (0.89–1.30) | 0.44 | 1.20 (1.01–1.43) | 0.04 | 1.18 (0.95–1.45) | 0.13 | 1.24 (0.98–1.56) | 0.07 |
EPIC | ||||||||||||
Urinary | 0.98 (0.95–1.01) | 0.17 | 0.98 (0.96–1.00) | 0.02 | 1.00 (0.98–1.02) | 0.68 | 0.97 (0.96–0.99) | 0.006 | 1.00 (0.98–1.02) | 0.81 | 0.95 (0.93–0.98) | < 0.001 |
Bowel | 0.96 (0.90–1.03) | 0.30 | 0.95 (0.92–0.99) | 0.01 | 0.98 (0.94–1.01) | 0.19 | 0.99 (0.96–1.02) | 0.56 | 0.97 (0.93–1.00) | 0.07 | 0.95 (0.91–1.00) | 0.05 |
Sexual | 0.97 (0.96–0.99) | < 0.001 | 1.00 (0.99–1.02) | 0.61 | 0.99 (0.97–1.00) | 0.01 | 0.98 (0.97–1.00) | 0.007 | 0.96 (0.95–0.98) | < 0.001 | 0.97 (0.96–0.98) | < 0.001 |
Ref., Reference; ADT, androgen deprivation therapy; dx, diagnosis.
The two items that could be confounded with side effects from androgen deprivation therapy were excluded from this scale for analysis (experiencing hot flushes, and going through a change of life like women do). Bolding in the table denotes a statistically significant result.